Histoplasmosis: Difference between revisions
Jump to navigation
Jump to search
Line 40: | Line 40: | ||
==Treatment== | ==Treatment== | ||
[[Histoplasmosis medical therapy|Medical Therapy]] | | [[Histoplasmosis medical therapy|Medical Therapy]] | [[Histoplasmosis surgery|Surgery]] | [[Histoplasmosis primary prevention|Primary Prevention]] | [[Histoplasmosis secondary prevention|Secondary Prevention]] | [[Histoplasmosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Histoplasmosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 15:58, 26 September 2012
Histoplasmosis | |
Histoplasma capsulatum. Methenamine silver stain showing histopathologic changes in histoplasmosis. | |
ICD-10 | B39 |
ICD-9 | 115 |
DiseasesDB | 5925 |
MedlinePlus | 001082 |
MeSH | D006660 |
Histoplasmosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Histoplasmosis On the Web |
American Roentgen Ray Society Images of Histoplasmosis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Ajellomyces capsulatus; Darling disease; Darling's disease
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Histoplasmosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
- Histoplasmosis Resource Guide from the National Eye Institute (NEI).
- NIOSH - Histoplasmosis - Protecting Workers at Risk